Free Trial

Gravity (GRVY) Competitors

Gravity logo
$65.39 -1.23 (-1.85%)
Closing price 04:00 PM Eastern
Extended Trading
$65.04 -0.35 (-0.54%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRVY vs. GDRX, LZ, DGNX, VVX, XMTR, ASTH, CRTO, IBTA, PHR, and OLO

Should you be buying Gravity stock or one of its competitors? The main competitors of Gravity include GoodRx (GDRX), LegalZoom.com (LZ), Diginex (DGNX), V2X (VVX), Xometry (XMTR), Astrana Health (ASTH), Criteo (CRTO), Ibotta (IBTA), Phreesia (PHR), and OLO (OLO). These companies are all part of the "business services" industry.

Gravity vs.

GoodRx (NASDAQ:GDRX) and Gravity (NASDAQ:GRVY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability.

Gravity has higher revenue and earnings than GoodRx. Gravity is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$797.41M1.73-$8.87M$0.0848.31
Gravity$500.85B0.00$105.61M$8.247.97

GoodRx has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, Gravity has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.

Gravity has a net margin of 14.98% compared to GoodRx's net margin of -2.05%. Gravity's return on equity of 34.76% beat GoodRx's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx-2.05% 5.35% 2.51%
Gravity 14.98%34.76%28.79%

GoodRx presently has a consensus target price of $6.55, indicating a potential upside of 69.35%. Given GoodRx's stronger consensus rating and higher probable upside, equities research analysts plainly believe GoodRx is more favorable than Gravity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.64
Gravity
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, GoodRx had 1 more articles in the media than Gravity. MarketBeat recorded 9 mentions for GoodRx and 8 mentions for Gravity. GoodRx's average media sentiment score of 0.94 beat Gravity's score of 0.64 indicating that GoodRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GoodRx
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Gravity
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.8% of GoodRx shares are held by institutional investors. Comparatively, 9.9% of Gravity shares are held by institutional investors. 4.5% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Gravity received 116 more outperform votes than GoodRx when rated by MarketBeat users. Likewise, 61.69% of users gave Gravity an outperform vote while only 39.57% of users gave GoodRx an outperform vote.

CompanyUnderperformOutperform
GoodRxOutperform Votes
74
39.57%
Underperform Votes
113
60.43%
GravityOutperform Votes
190
61.69%
Underperform Votes
118
38.31%

Summary

Gravity beats GoodRx on 10 of the 19 factors compared between the two stocks.

Get Gravity News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRVY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRVY vs. The Competition

MetricGravityData processing & preparation IndustryComputer SectorNASDAQ Exchange
Market Cap$456.49M$4.28B$25.49B$8.53B
Dividend YieldN/A3.85%2.89%4.11%
P/E Ratio7.3285.6645.0319.97
Price / Sales0.001,487.272,087.85122.22
Price / Cash3.9633.7434.7834.62
Price / Book1.236.436.774.59
Net Income$105.61M$44.05M$739.33M$248.18M
7 Day Performance1.81%-0.95%0.23%2.15%
1 Month Performance12.04%28.52%15.98%16.14%
1 Year Performance-8.65%19.61%52,512.26%8.06%

Gravity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRVY
Gravity
1.3034 of 5 stars
$65.39
-1.8%
N/A-10.5%$454.40M$500.85B7.28340News Coverage
GDRX
GoodRx
3.8373 of 5 stars
$4.35
+0.7%
$7.60
+74.8%
-44.3%$1.67B$792.32M-145.00950Gap Up
High Trading Volume
LZ
LegalZoom.com
1.703 of 5 stars
$9.42
+4.3%
$9.19
-2.5%
+11.0%$1.66B$690.78M72.471,220News Coverage
Positive News
Analyst Forecast
DGNX
Diginex
N/A$73.16
+11.5%
N/AN/A$1.66B$1.18M0.0021Positive News
Gap Down
VVX
V2X
3.1935 of 5 stars
$51.45
+1.7%
$63.67
+23.7%
+2.7%$1.63B$4.33B183.768,100Gap Up
XMTR
Xometry
1.4284 of 5 stars
$32.31
+5.9%
$34.89
+8.0%
+115.5%$1.63B$573.81M-30.77790
ASTH
Astrana Health
4.175 of 5 stars
$28.54
-3.9%
$53.29
+86.7%
-30.7%$1.60B$2.03B21.951,900Gap Up
CRTO
Criteo
3.7144 of 5 stars
$29.56
+3.9%
$46.70
+58.0%
-26.2%$1.59B$1.93B17.603,720Gap Up
IBTA
Ibotta
1.7169 of 5 stars
$49.71
+2.9%
$50.00
+0.6%
N/A$1.54B$367.25M27.77N/ATrending News
Earnings Report
PHR
Phreesia
4.2878 of 5 stars
$26.02
+1.6%
$31.33
+20.4%
+7.2%$1.53B$419.81M-17.701,700News Coverage
Positive News
Upcoming Earnings
OLO
OLO
2.1347 of 5 stars
$9.18
+6.1%
$9.00
-1.9%
+89.1%$1.52B$284.94M-91.74710Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:GRVY) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners